Tissue Regenix Group PLC | Mutual Funds
Mutual Funds that own Tissue Regenix Group PLC
CF Woodford Equity Income
234,212,642
19.98%
0
0.34%
07/31/2018
Invesco Perpetual UK Invt. Ser. - High Income
211,446,407
18.05%
0
0.19%
03/29/2018
Invesco Perpetual UK 2 Invt. Series - Income Fund
125,263,532
10.69%
0
0.24%
03/29/2018
Jupiter UK Growth Fund
66,907,301
5.71%
0
0.49%
02/28/2018
Old Mutual Woodford Equity Income Fund
25,550,000
2.18%
0
1.45%
07/31/2018
Edinburgh Worldwide Investment Trust Plc
17,335,826
1.48%
0
0.32%
10/31/2017
Henderson UK & Europe Funds - UK Equity Income Fund
16,696,500
1.43%
0
0.43%
07/31/2018
Baillie Gifford Overseas Growth Fund - Global Discovery Fund
13,900,000
1.19%
0
0.24%
04/30/2018
Baillie Gifford UK & Balanced Fund - British Smaller Companies
13,308,769
1.13%
0
0.6%
04/30/2018
Jupiter Primadona Growth Trust Plc
2,666,251
0.23%
855,220
0.26%
01/31/2018
| Address |
Astley Lane Industrial Estate
Leeds Yorkshire LS26 8XT
United Kingdom
|
|
Employees
|
- |
| Website |
http://tissueregenix.com |
| Updated |
07/08/2019 |
| Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The potential applications of this process address clinical needs such as vascular disease, heart valve replacement and knee repair. |
